Min Ai

Changzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Nitrate removal by acid-tolerant Fictibacillus phosphorivorans MJ9 in acidic anaerobic environments.

Nitrate removal by acid-tolerant Fictibacillus phosphorivorans MJ9 in acidic anaerobic environments.

Journal: RSC advances

Published: February 09, 2026

PD-1 inhibitors combined with tyrosine kinase inhibitor-associated hypothyroidism is a predictive factor for antitumor effectiveness in male patients with hepatocellular carcinoma.

PD-1 inhibitors combined with tyrosine kinase inhibitor-associated hypothyroidism is a predictive factor for antitumor effectiveness in male patients with hepatocellular carcinoma.

Journal: Oncology letters

Published: November 11, 2025

Retrospective Analysis of the Clinical Efficacy, Safety, and Influencing Factors of Drug-Eluting Bead Transarterial Chemoembolization for Unresectable Hepatic Malignancies.

Retrospective Analysis of the Clinical Efficacy, Safety, and Influencing Factors of Drug-Eluting Bead Transarterial Chemoembolization for Unresectable Hepatic Malignancies.

Journal: Clinical Medicine Insights. Oncology

Published: August 30, 2025

Association between liver stiffness measurement and portal vein thrombosis among patients with cirrhosis: A cross-sectional study.

Association between liver stiffness measurement and portal vein thrombosis among patients with cirrhosis: A cross-sectional study.

Journal: Medicine

Published: July 22, 2025

Optimization of 1-Methyl-3-(pyridin-3-yl)-1H-indol Derivatives as ROR1 Inhibitors with Improved Activity and Selectivity.

Optimization of 1-Methyl-3-(pyridin-3-yl)-1H-indol Derivatives as ROR1 Inhibitors with Improved Activity and Selectivity.

Journal: Journal of medicinal chemistry

Published: June 02, 2025

Mechanisms underlying acid tolerance in Lysinibacillus sp. ND7, a highly efficient nitrate degrader.

Mechanisms underlying acid tolerance in Lysinibacillus sp. ND7, a highly efficient nitrate degrader.

Journal: PloS one

Published: May 07, 2025

Structure-directing optimization of N-(2,3-dihydrobenzo[b] [1,4]dioxin-6-yl)benzamide derivatives as selective receptor tyrosine kinase-like orphan receptor 1 (ROR1) inhibitors for cancer therapy.

Structure-directing optimization of N-(2,3-dihydrobenzo[b] [1,4]dioxin-6-yl)benzamide derivatives as selective receptor tyrosine kinase-like orphan receptor 1 (ROR1) inhibitors for cancer therapy.

Journal: European journal of medicinal chemistry

Published: March 25, 2025

Rational Design, Synthesis, and Biological Evaluation of Novel c-Met Degraders for Lung Cancer Therapy.

Rational Design, Synthesis, and Biological Evaluation of Novel c-Met Degraders for Lung Cancer Therapy.

Journal: Journal of medicinal chemistry

Published: January 30, 2025

Structure-Guided Optimization and Preclinical Evaluation of 6-O-Benzylguanine-Based Pin1 Inhibitor for Hepatocellular Carcinoma Treatment.

Structure-Guided Optimization and Preclinical Evaluation of 6-O-Benzylguanine-Based Pin1 Inhibitor for Hepatocellular Carcinoma Treatment.

Journal: Journal of medicinal chemistry

Published: January 27, 2025

Publisher Correction: High-performance bacterium-enhanced dual-compartment microbial fuel cells for simultaneous treatment of food waste oil and copper-containing wastewater.

Publisher Correction: High-performance bacterium-enhanced dual-compartment microbial fuel cells for simultaneous treatment of food waste oil and copper-containing wastewater.

Journal: Scientific reports

Published: December 11, 2024

Atg7 in CD4+ T cells improves intestinal mucosal inflammation by regulating Ets1-mediated T cell differentiation.

Atg7 in CD4+ T cells improves intestinal mucosal inflammation by regulating Ets1-mediated T cell differentiation.

Journal: Clinical and translational medicine

Published: November 01, 2024

Targeting oncogenic transcriptional factor c-myc by oligonucleotide PROTAC for the treatment of hepatocellular carcinoma.

Targeting oncogenic transcriptional factor c-myc by oligonucleotide PROTAC for the treatment of hepatocellular carcinoma.

Journal: European journal of medicinal chemistry

Published: September 02, 2024

Showing 1-12 of 45

Last Updated: 09/26/2026